| ORIGINAL ARTICLE |
|
| Year : 2020 | Volume
: 9
| Issue : 4 | Page : 209-214 |
|
|
Retrospective cohort study on the symptomatic recurrence pattern after hysteroscopic polypectomy
Jorge Cea Garcia1, Antonio Jiménez Caraballo1, MarÍa del Mar Rios Vallejo2, Ignacio Zapardiel3
1 Department of Gynecology, Clinical Management Unit of Obstetrics and Gynecology, Virgen Macarena University Hospital, Seville, Spain
2 Department of Gynecology, Puerta de Hierro Majadahonda University Hospital, Madrid, Spain
3 Department of Gynecology, La Paz University Hospital, Madrid, Spain
Correspondence Address:
Dr. Jorge Cea Garcia
Clinical Management Unit of Obstetrics and Gynecology, Virgen Macarena University Hospital, Seville
Spain
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/GMIT.GMIT_102_19
|
|
|
Objectives: The recurrence rate of benign endometrial polyps after a hysteroscopic polypectomy is low, between 0% and 15%. There are limited follow-up duration data on recurrence factors for benign polyps after hysteroscopic polypectomy, including recurrences with Versapoint® versus resectoscope. This study aims to estimate the rate of symptomatic recurrence following hysteroscopic polypectomy and to analyze the possible risk factors involved with Versapoint® versus resectoscope.
Materials and Methods: We designed a retrospective cohort study in a tertiary university hospital in Seville (Spain) which looked at the results of polypectomy with a 9-mm resectoscope on 42 women between 2008 and 2015 compared to 151 women using Versapoint® during 2014.
Results: The rate of first recurrence was 24.35%. There was a strong positive correlation between the recurrence and the follow-up duration (odds ratio [OR] = 2.58; 95% confidence interval [CI] = 1.68–5.04; P = 0.000), the polyps causing abnormal uterine bleeding (OR = 2.5; 95% CI: 1.1–3; P = 0.04), and a polyp size >15 mm (OR = 1.63; 95% CI = 1.3–3.1; P = 0.02). There were no statistical differences in polyps' recurrence among the types of hysteroscopic polypectomy (P > 0.05).
Conclusion: The main risk factors for recurrence were polyps causing abnormal uterine bleeding, size, and follow-up duration.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
